top of page

Mwandishi:

ULY CLINIC

Mhariri:

Dkt. Mangwella S, MD

3 Novemba 2021, 09:51:21

Cefixime inatibu nini?

Cefixime inatibu nini?

Cefixime ni antibayotiki kizazi cha tatu cha cephalosporin. Hutumika kutibu maradhi mbalimbali kutokana na bakteria jamii ya gramu chanya na hasi.


Vimelea wanaodhuriwa na cefixime


  • Staphylococcus aureus

  • Streptococcus pneumonia

  • Streptococcus pyogenes

  • Hemophilus influenza

  • Moraxella catarrhalis

  • Eschelician coli

  • Klebsiella

  • Proteus mirabilis

  • Salmonella

  • Shigella

  • Neisseria gonorrhoeae


Kumbuka, kutokana na matumizi ya dawa yasiyo sahihi pamoja na kubadilika kwa utu wa vimelea vya maradhi, cefixime inaweza isifanye kazi yake ya kuua baadhi ya vimelea viivyoorodheshwa hapo juu.


Cefixime inatibu nini?


Cefixime inatibu magonjwa yanayosababiswha na bakteria wanaodhuriwa na dawa hii. Baadhi ya magonjwa yanayotibiwa na Cefixime ambapo inapaswa kutumika yenyewe au ikiwa imechanganyika na dawa zingine ni;


  • Bronkaitiz

  • Gono

  • Otitis

  • Pharyngitis

  • Tonses

  • U.T.I


Wapi unapata maelezo zaidi kuhusu cefixime?


Pata maelezo zaidi kuhusu cefixime katika makala za dawa sehemu nyingine katika tovuti hii.

ULY CLINIC inakushauri uwasiliane na daktari wako kwa ushauri na tiba kabla ya kuchukua hatua yoyote ile baada ya kusoma majibu haya.

Kupata ushauri zaidi au tiba kutoka kwa daktari wa ULY CLINIC bofya hapa au tumia linki ya Pata tiba

Imeboreshwa,

3 Novemba 2021, 10:27:52

Rejea za mada hii

  1. Cefixime (Suprax) . https://www.medicinenet.com/cefixime/article.htm. Imechukuliwa 03/11/2021

  2. Takahata S, et al: Amino acid substitutions in mosaic penicillin-binding protein 2 associated with reduced susceptibility to cefixime in clinical isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother. 2006 Nov;50(11):3638-45. Epub 2006 Aug 28.

  3. Zhao S, et al. Genetics of chromosomally mediated intermediate resistance to ceftriaxone and cefixime in Neisseria gonorrhoeae. Antimicrob Agents Chemother. 2009 Sep;53(9):3744-51. doi: 10.1128/AAC.00304-09. Epub 2009 Jun 15.

bottom of page